The software assists radiologists during reviews of CT colonography (CTC, a.k.a. virtual colonoscopy) images by automatically highlighting potential colorectal polyps, which are possible precursors to colorectal cancer.
Medicsight PLC and Ziosoft Inc., have announced the integration of Medicsight’s ColonCAD API software and Ziosoft’s Ziostation. Ziosoft, based in Redwood City, Calif., will distribute the technologies in the United States under the terms of the deal.
The FDA approved ColonCAD API for clinical use in May. The software assists radiologists during reviews of CT colonography (CTC, a.k.a. virtual colonoscopy) images by automatically highlighting potential colorectal polyps, which are possible precursors to colorectal cancer. The FDA’s green light came after a clinical trial involving 15 radiologist readers who each reviewed 112 patient CT colonography cases. When assisted by ColonCAD, radiologists’ accuracy for detecting polyps of all sizes was significantly improved compared with unassisted reading, Medicsight officials said.
“The partnership between Ziosoft and Medicsight should make a compelling match for CT colonography interpretation,” said Perry J. Pickhardt, professor of Radiology at the University of Wisconsin, one of the first U.S. sites slated to use the combined Medicsight and Ziosoft technologies. “CTC will definitely benefit from the pairing of these companies which are two recognized leaders in the advanced visualization field.”
Ziosoft holds numerous clearances for applications for its supercomputing visualization and functional analytics technology. Medicsight and Ziosoft have been partnering in Europe prior to the U.S. clearance of ColonCAD software.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.